On Monday, Rock Health – a health technology accelerator, based in San Francisco – announced 8 new portfolio companies. These 8 new companies are all across the health spectrum, in terms of product offerings:
These latest companies are tackling broad areas of healthcare, including issues in biotechnology, chronic disease, and healthcare regulation. We are thrilled by not only the sheer number of entrepreneurs building digital health companies, but also the incredible diversity of ideas. With these additions, we have a diverse and active portfolio of 55 digital health companies across the country.1
Here is a quick look at each of the 6 companies – two of the 8 new portfolio companies are unnamed, as they are in stealth mode:
- Accountable is an online platform that guides companies step-by-step through the process of becoming HIPAA compliant.
- Acumen is building a digital platform to allow doctors to evaluate and manage neurological disorders through analysis of patient video.
- Aptible gives developers a secure deployment platform and tools to manage HIPAA compliance for web and mobile applications. Also backed by Y Combinator, Aptible launched publicly in August 2014.
- Benchling is a cloud-based data management and collaboration platform for life science R&D.
- TelePharm is a web and mobile app that provides efficient pharmacy care by allowing pharmacists and patients to connect online, anytime, anywhere. TelePharm recently closed a $2.5M Series A led by medical tech venture capitalist John Pappajohn and Iowa state Board of Regents President Bruce Rastetter.
- Welkin Health‘s coaches drive behavior change by offering daily support to patients with type 2 diabetes through an easy-to-use smartphone application. Welkin recently released its Android app and kicked off its first two partnerships with care organizations to prescribe its product to their patients. 2
In addition to adding 8 new portfolio companies, Rock Health also announced that it had added 3 new corporate partners. These new partners are Blue Shield of California; the pharmaceutical giant Abbott; and the health wing of Deloitte Consulting.